Latest news

17/12/2019

First map of circular DNA in childhood cancer

Press release by the Charité Berlin. Cancer development is associated with the gradual accumulation of DNA defects over time. Thus, cancer is considered an age-related disease. But why do children…

05/12/2019

Better understanding the development of aggressive embryonic brain tumors

Scientists from the Hopp Children's Cancer Center Heidelberg (KiTZ) and the German Cancer Consortium (DKTK) present the most comprehensive analyses of a group of particularly aggressive brain tumors…

22/10/2019

Bispecific antibody to be tested for treatment of prostate cancer

A press release by the Universitätsklinikum Tübingen. Prostate carcinoma is the most common type of cancer in men. If the tumor metastasizes, it is not curable by established treatment…

17/10/2019

Cancer Core Europe Summer School 2019 – Emerging talent in the field of cancer research

At the Summer School for Translational Cancer Research in Albufeira, Portugal, from 7 to 11 October, young physicians and scientists came together to discuss topical issues in cancer medicine and to…

07/10/2019

Influential fusion partner of a new cancer-driver protein

Cancer treatments are increasingly making use of drugs that target cancer-driver mutations. In many types of cancer, a driver mutation is found in the region of the BRAF gene. Researchers from the…

12/09/2019

Machine learning improves the diagnosis of patients with head and neck cancers

Joint press release by Charité – Universitätsmedizin Berlin and Technische Universität Berlin. Researchers from Charité – Universitätsmedizin Berlin and the German Cancer Consortium (DKTK) have…

26/07/2019

Precision medicine and transgene T cells: 6th Munich Cancer Retreat in Herrsching am Ammersee

„An exciting overview over the field of precision oncology” was given by Christophe Le Tourneau, lead of landmark trials such as SHIVA 01 and 02 as mentioned by Michael von Bergwelt (deputy…

18/07/2019

Making cancer stem cells visible to the immune system - New results may enable innovative treatment concept against leukemia

Joint press release of the German Cancer Research Center (DKFZ), the German Cancer Consortium (DKTK), and the University Hospital Tübingen. Leukemia stem cells protect themselves against the immune…

24/06/2019

Focus on BAP1 for the diagnosis and therapy of kidney cancer and uveal melanoma

Introducing Samuel Peña-Llopis at DKTK Essen/Düsseldorf Samuel Peña-Llopis is leading the new young investigator group for Translational Genomics in Solid Tumors at the partner site Essen/Düsseldorf…

13/06/2019

Not silent at all

The so-called "silent" or "synonymous" genetic alterations do not result in altered proteins. But they can nevertheless influence numerous functions of the cell and thus also disease processes.…

05/06/2019

Stomach and colorectal cancer: Identifying patients at an early stage who are suitable for artificial intelligence immunotherapy.

Press release of the NCT Heidelberg. Changes in certain sections of the genetic material of cancer cells, so-called microsatellites, can provide an important indication of whether immunotherapy…

29/04/2019

Fighting colon cancer with killer cells

Genetically modified immune cells can successfully destroy colon cancer cells. This has been demonstrated for the first time by scientists from the German Cancer Consortium (DKTK) at Georg Speyer…

11/04/2019

Targeted approach to therapy for rare type of bone cancer

Press release by NCT Heidelberg. Chordomas are rare bone tumors for which only few options of treatment exist. Scientists and doctors from the National Center for Tumor Diseases (NCT), the German…

04/04/2019

UA Ruhr Researchers Jointly Develop Basis for Targeted Cancer Therapy

Press release of the TU Dortmund. From basic research to application – the way to drug discovery is long. Scientists from TU Dortmund University, the Medical Faculty of the University of…

03/04/2019

Our medicine is research

The aim of SYNERGIE, the new magazine published jointly by the German Centers of Health Research (DZG,) is to present modern medical research and provide a brief digest of the latest research…

25/03/2019

Cancer research must have a social impact – A new strategy concept for Europe

Curing cancer is one of five key focus areas of Horizon Europe, the new European framework program for research and innovation. This was decided by the Competetiveness Council of the European Union in…

21/03/2019

The evolution of brain tumors

Scientists from the German Cancer Research Center and German Cancer Consortium (DKTK) found in a recent study that only three different genetic alterations drive the early development of malignant…

21/02/2019

Colon cancer: Different Wnt signaling pathways lead colon cells astray

Signaling molecules in the Wnt family are some of the most essential messengers for continuous regeneration of our stressed colon mucosa. At the same time, “too much” Wnt is a frequent trigger for…

31/01/2019

Psychiatric drug as a new treatment for leukemia

A new kind of leukemia treatment using an antidepressant could offer a new option to patients who are resistant to current therapies. German Cancer Consortium (DKTK) scientists working at the…

28/01/2019

New biomarker to monitor skin cancer therapies

Press release of UDE/University Hospital Essen Merkel cell carcinoma is a rare but highly aggressive form of skin cancer that is triggered by a virus or by UV light. A biomarker that can monitor the…